| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 10/20/2004 | EP1469003A2 Tetraphosphonate bicyclic trisanhydrides |
| 10/20/2004 | EP1468112A2 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for pcr analysis |
| 10/20/2004 | EP1468007A2 Pseudonucleotide comprising an intercalator |
| 10/20/2004 | EP1468006A1 Enzymatic redox labelling of nucleic acids |
| 10/20/2004 | CN1539014A Templated molecules and methods for using such molecules |
| 10/20/2004 | CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 10/19/2004 | CA2168843C Thermodynamically stable crystal form of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b benzoic acid salt and processes for its preparation |
| 10/14/2004 | WO2004088312A2 Fluorescently tagged ligands |
| 10/14/2004 | WO2004087939A1 A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia |
| 10/14/2004 | WO2004086949A2 Dna markers for management of cancer |
| 10/14/2004 | WO2004070052A3 Compounds and processes for single-pot attachment of a label to nucleic acid |
| 10/14/2004 | WO2004057010A3 Deoxyribonucleotides manufacturing by enzymatic reduction of ribonucleotides |
| 10/14/2004 | WO2004052905A3 Antiviral nucleoside derivatives |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists |
| 10/14/2004 | CA2521113A1 Fluorescently tagged ligands |
| 10/13/2004 | EP1466919A1 Nucleotide analogs with six membered rings |
| 10/13/2004 | EP1466663A1 Quality control method for manufacturing nucleic acid arrays |
| 10/13/2004 | EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid |
| 10/13/2004 | EP1466606A2 Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons |
| 10/13/2004 | EP1466014A2 Chemical and biological hazard sensor system and methods thereof |
| 10/13/2004 | EP1003762B1 Base analogues |
| 10/13/2004 | CN1537115A C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 10/13/2004 | CN1535978A Circular muscle glycoside diphosphoethoxymethyl ribose compound |
| 10/13/2004 | CN1535977A Method for separating DNA sodium from DNA sodium zymohydrolysate and purifying it |
| 10/12/2004 | US6803457 Adenosine receptors; for reduction of tissue damage resulting from hypoxia/cardiovascular disorders in mammals/humans |
| 10/12/2004 | US6803455 Inhibitors of nucleoside metabolism |
| 10/12/2004 | US6803198 Carbamate-derivatized nucleosides and oligonucleosides |
| 10/07/2004 | WO2004085454A1 Silylated oligonucleotide compounds |
| 10/07/2004 | WO2004085453A1 Synthesis and method of purification of cyclic nucleotide derivatives |
| 10/07/2004 | WO2004069171A3 Novel compounds for the treatment of sickle cell disease |
| 10/07/2004 | WO2004060902A3 Novel nucleoside transport inhibitors |
| 10/07/2004 | US20040198972 Using synthesis process which combines oxidation and capping into a single step to generate modified nucleotide sequences for use as viricidal agents and antisense agents |
| 10/07/2004 | US20040198966 1-{3'-O-benzoyl-4'-O-[(4,4'-dimethoxytriphenyl)methyl]- beta -D-ribopyranosy}thymine preparation using solid phase synthesis |
| 10/07/2004 | US20040198693 Purine-type compounds: A3 agonists |
| 10/07/2004 | US20040198692 C-pyrazole A2A receptor agonists |
| 10/07/2004 | US20040197851 Two-stage protective groups for the synthesis of biopolymers |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/06/2004 | EP1464708A1 A process for the preparation of fludarabine phosphate from 2-fluoroadenine |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 10/06/2004 | EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 10/06/2004 | EP0832299A4 Use of nucleic acid ligands in flow cytometry |
| 10/06/2004 | CN1535278A Process for preparation of L-ribavirin |
| 10/06/2004 | CN1535277A Process for preparation of L-ribavirin |
| 10/06/2004 | CN1169823C Preparation method of 2,2'-anhydro uridine compound |
| 10/05/2004 | US6800751 Reagent and process for protecting nucleoside hydroxyl groups |
| 10/05/2004 | US6800743 Pyrimidine derivatives for labeled binding partners |
| 10/05/2004 | US6800742 Method for producing β-D-ribofuranose derivatives or optical isomers thereof |
| 10/05/2004 | US6800629 Pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof |
| 10/05/2004 | US6800439 Methods for improved array preparation |
| 10/05/2004 | CA2463719A1 Nucleotide analogs with six membered rings |
| 09/30/2004 | WO2004084453A2 METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES |
| 09/30/2004 | WO2004083258A2 Branched water-soluble polymers and their conjugates |
| 09/30/2004 | WO2004083228A1 Indolopyrrolocarbazole derivatives and antitumor agents |
| 09/30/2004 | WO2004083186A1 Therapeutic agent for viral hepatitis and carcinostatic agent |
| 09/30/2004 | WO2004083155A2 Nucleotide lipid ester derivatives |
| 09/30/2004 | WO2004082822A2 Methods for isolating crystalline form i of 5-azacytidine |
| 09/30/2004 | WO2004082619A2 Forms of 5-azacytidine |
| 09/30/2004 | WO2004082618A2 Synthesis of 5-azacytidine |
| 09/30/2004 | WO2004012667A3 Photoactivated anti-viral and anti-cancer agent |
| 09/30/2004 | US20040192918 Controlling gene expression; antisense agents; nuclease resistance |
| 09/30/2004 | US20040192904 Process for the preparation of ribavirin |
| 09/30/2004 | US20040192651 substituted cyclic phosphate diesters of 1-aryl-1,3-propane diols, that have the trans-stereochemistry and their use to synthesize phosphate prodrugs that have the cis-configuration; use of these trans-phosphorylating reagents for the stereoselective synthesis of cis-phosphate prodrugs |
| 09/30/2004 | US20040192635 administration of acyl derivatives of 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, and 2'-deoxythymidine; prevent or treat radiation, sunlight and mutagen-induced cellular damage, improve the healing of wounds, repair damaged tissues, physiological and and pathological tissues conditions |
| 09/30/2004 | US20040192553 Inosine L-Arginine salt and uses thereof |
| 09/30/2004 | US20040191824 Preparing nucleoside or nucleotide comprising a pyrazolopyrimidine base |
| 09/30/2004 | DE20220947U1 New pyrrolo(2,3-d)pyrimidine nucleoside analogs useful as immunomodulators for treatment of cancer and autoimmune diseases |
| 09/30/2004 | CA2519434A1 Nucleotide lipid ester derivatives |
| 09/30/2004 | CA2519092A1 Branched water-soluble polymers and their conjugates |
| 09/30/2004 | CA2518973A1 Methods for isolating crystalline form i of 5-azacytidine |
| 09/29/2004 | EP1461041A2 Preparation of intermediates useful in the synthesis of antiviral nucleosides |
| 09/29/2004 | EP1461033A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 09/29/2004 | EP1090019B1 Adenosine derivatives |
| 09/29/2004 | EP1090018B1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 09/29/2004 | CN1168735C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 09/29/2004 | CN1168452C Use of methoxymorpholino dexorubicin for treatment of liver tumor |
| 09/23/2004 | WO2004080466A1 Cytidine analogs and methods of use |
| 09/23/2004 | WO2004055198A3 Device and method for in-line blood testing using biochips |
| 09/23/2004 | WO2004038006A3 Purine nucleosides |
| 09/23/2004 | US20040186284 Methods for isolating crystalline form I of 5-azacytidine |
| 09/23/2004 | US20040186283 Synthesis of 5-azacytidine |
| 09/23/2004 | US20040186282 Synthesis and method of purification of cyclic nucleotide derivatives |
| 09/23/2004 | US20040186281 Nucleotide derivative and DNA microarray |
| 09/23/2004 | US20040186065 Forms of 5-azacytidine |
| 09/23/2004 | US20040185466 to detect single nucleotide polymorphisms, genetic mutation, gene expression, forensic identification, disease association, DNA/genomic sequencing and translation/transcription analysis; solid phase synthesis |
| 09/22/2004 | EP1460082A1 Phospholipid esters of clofarabine derivatives |
| 09/22/2004 | EP1458735A2 Anti-viral 7-deaza l-nucleosides |
| 09/22/2004 | EP1458734A1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
| 09/22/2004 | EP1201678B1 Novel bicyclonucleoside analogues |
| 09/22/2004 | EP0841900B1 Pharmaceutical composition for detecting lung disease |
| 09/22/2004 | EP0775149B1 Novel protecting groups and use thereof in an improved process for oligonucleotide synthesis |
| 09/22/2004 | CN1530371A Fructose spiro-compound with anti-cancer activity |
| 09/22/2004 | CN1167709C N-pyrazole AZA receptor agonists |
| 09/22/2004 | CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 09/21/2004 | US6794138 Comprises in vitro transcription reaction; product used as template; solid phase synthesis |
| 09/16/2004 | WO2004079011A1 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004078994A2 Methods for detection of genetic disorders |
| 09/16/2004 | WO2004078993A2 Process for preparing dideoxyinosine using adenosine deaminase enzyme |
| 09/16/2004 | WO2004078933A2 Intracellular delivery of small molecules proteins and nucleic acids |